Megan Bailey

Director Ejecutivo en Personal Genome Diagnostics, Inc. .

Consumer Services

Health Technology

Perfil

Megan Bailey is currently the Chief Executive Officer at Personal Genome Diagnostics, Inc. She started this position in 2020.
Ms. Bailey has a background in education, having completed her undergraduate degree at the US Military Academy and her graduate degree at the University of North Carolina System.

Cargos activos de Megan Bailey

Empresas	Cargo	Inicio
Personal Genome Diagnostics, Inc. Personal Genome Diagnostics, Inc. BiotechnologyHealth Technology Personal Genome Diagnostics, Inc. provides cancer genome analysis to help researchers identify cancer-related genetic changes. The firm's product PDGx develops liquid biopsy technology that uses patient-specific tumor alterations to create a simple blood test that enables tumor detection and monitoring. It provides cancer genome analyses to oncology researchers, drug developers, clinicians and patients. The company was founded by Luis A. Diaz Jr. and Victor Velculescu in 2010 and is headquartered in Baltimore, MD.	Director Ejecutivo	21/04/2020

Todos los cargos activos de Megan Bailey

Formación de Megan Bailey.

US Military Academy	Undergraduate Degree
University of North Carolina System	Graduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Megan Bailey.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	1
Personal Genome Diagnostics, Inc. Personal Genome Diagnostics, Inc. BiotechnologyHealth Technology Personal Genome Diagnostics, Inc. provides cancer genome analysis to help researchers identify cancer-related genetic changes. The firm's product PDGx develops liquid biopsy technology that uses patient-specific tumor alterations to create a simple blood test that enables tumor detection and monitoring. It provides cancer genome analyses to oncology researchers, drug developers, clinicians and patients. The company was founded by Luis A. Diaz Jr. and Victor Velculescu in 2010 and is headquartered in Baltimore, MD.	Health Technology